Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
i was here when asfx went from .0006 - .04, i sold and have made cash here ever since. i have some left over, from about 2 years ago and i knew this would come back to life. looking forward to a nice run here to .006 - .03, good luck all. go $$ASFX$$....
i am guessing that its true..... ignorance is bliss, lol. i am loving how this is all coming together for $$MDIN$$, slowly but surely $$MDIN$$ will become a viable company. go $$MDIN$$.....
im hoping this does a turn-around, its about that time. it will pay-off eventually....
what a great e-mail, i for one feel alot better. i personally think it should not be posted here because it will be crucified regardless of its content. srwdiesel will most likely send it to you if you request it, and i hope you dont re-post it here. like i have always stated, im willing to wait for $$MDIN$$ to succeed. if you cant wait, get out now. if you can wait, hold'em, and stop with all the inpatients. i am long and strong, go [b]$$MDIN$$....
yeah, the money is coming imminently, sorry i couldn't re-sist. lol. no, no news about anything that i know about.
it wasn't long ago that some posting negatively once admitted that they do that so they can buy at low pps, they left for a good while and now they are back doing the same thing all over again. i dont post as much as i want to because i would get banned, just know this; i have complete faith in nick chieco and "MDIN". i have done my own dd and im very excited what is coming from this company that was once at .0001 for over a year and went to .01 in 9 months. i am long and strong with $$MDIN$$, and will wait as long as it takes, for this company to become viable and profitable, and imho it wont be to much longer. go $$MDIN$$....
p.s.--i just to say hello to dirty pop, welcome back. now i know $$MDIN$$ will be taking off sooner then i thought, lmao....
im also sticking around, i was in a dead one for 2 years @ .0001 no bid. 12mil shares, now its @ .0065 and i couldnt be happier. you never,ever know whats going to happen in a pinkie. good luck and go asfx.....
scroll down.......
American Scientific Resources Inc.
OTN: ASFX GO
Set AlertsFind a Broker
Add to WatchlistTrade at E*TRADE
OVERVIEW PROFILE NEWS CHARTS FINANCIALS HISTORICAL QUOTES ANALYST ESTIMATES OPTIONS SEC FILINGS HULBERT INSIDERS
Countdown to close --Quotes are delayed by 20 min
Apr 9, 2014 12:30 p.m.
$0.00
+0.00 +100.00%
Volume 102,735
10a11a12p1p2p3p
Previous close
$ 0.0001
Day low
Day high
$0.0002
$0.0002
52 week low
52 week high
$0.0001
$0.0004
Company Description
American Scientific Resources, Inc. is a consumer product manufacturer, which manufactures and distributes emerging medical products. The company specializes in the clinical, home healthcare, infant and juvenile product industries. It sources and designs innovative health and safety products, develo...
Valuation
P/E Current
-0.01
P/E Ratio (with extraordinary items)
0.00
Price to Sales Ratio
10.05
Enterprise Value to EBITDA
-0.87
Enterprise Value to Sales
2.48
Total Debt to Enterprise Value
0.23
Efficiency
Receivables Turnover
12.02
Total Asset Turnover
0.40
Liquidity
Current Ratio
0.07
Quick Ratio
0.02
Cash Ratio
0.00
Profitability
Gross Margin
12.46
Operating Margin
-369.62
Pretax Margin
-816.44
Net Margin
-816.44
Return on Assets
-324.46
Capital Structure
Total Debt to Total Assets
242.47
Officers and Executives
Name Age Officer Since Title
Mr. Howard J. Taylor 52 2011 Director
Insider Actions
please read this, it seems important........
TMC NEWS
TMCNET eNEWSLETTER SIGNUP
SUBMIT
[color=red][April 02, 2014][/color]
INDEPENDENCE ENERGY CORP. FILES (8-K) Disclosing Change in Directors or Principal Officers, Financial Statements and Exhibits
digg
(Edgar Glimpses Via Acquire Media NewsEdge) Item 5.02, Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Asset Purchase Agreement with American Medical Distributors, LLC On March 31, 2014, Independence Energy Corp. ("we", "us","our") entered into and closed an Asset Purchase Agreement (the "Agreement") dated for reference March 31, 2014 with American Medical Distributors, LLC ("AMD"). Pursuant to the agreement we have acquired from AMD all right, title and interest of AMD in and to a certain distribution contract (the "HuBDIC Agreement") dated November 27, 2013 with HuBDIC Co. Ltd. ("HuBDIC"), a Korea corporation, pursuant to which AMD has been granted the exclusive right to distribute in the Americas certain professional and consumer grade non-touch thermometers known as the FS700 Pro and FS-700 (retail version), and any future versions. As additional consideration, we have also received $60,000 and any assets of AMD related to its distribution business, including, all sales leads and related materials (collectively, including the HuBDIC Agreement, the "AMD Assets").
The material terms of the HuBDIC Agreement are as follows: (a) term of 5 years from November 7, 2013; (b) subject to FDA approval of the HuBDIC products, which is anticipated, we are required to purchase a minimum of 3,000 product units for re-sale during year 1 of the distribution period, 8,000 during year 2, and 15,000 during each subsequent year; (c) a $10,000 distribution fee paid to HuBDIC by AMD will be credited toward the first product order; and (d) the deposit is refundable to us at our election, and we may terminate the HuBDIC Agreement in the event FDA approval is not granted by April 26, 2014.
In consideration of the AMD Assets, we have agreed to distribute to four designees of AMD an aggregate of 152,172,287 shares of our common stock. These securities were issued to four accredited investors pursuant to the exemption from registration provided for under Rule 506 of Regulation D, promulgated under the United States Securities Act of 1933, as amended.
Appointment of Directors and Officer On March 31, 2014 our board of directors appointed Howard Taylor as Chief Executive Officer and director of our company, and Daniel Schreiber as a director of our company. Mr. Taylor will also serve as Chairman of the board of directors. Our board of directors now consists of Gregory Rotelli, Howard Taylor and Daniel Schreiber. Mr. Rotelli, who resigned as Chief Executive Officer prior to Howard Taylor's appointment, continues to serve as President, Chief Financial Officer, Secretary and Treasurer of our Company. There are no familial relationships amongst our directors and officers.
Howard J. Taylor, Chief Executive Officer, Director, and Chairman of the Board Since 1995, Howard J. Taylor has been CEO of Concorde Capital Limited, a private Investment Banking and consulting company focused on the sourcing, structuring, funding and management of private placements and private equity transactions. Is this capacity Mr. Taylor has overseen numerous investments and placements of transactions across a broad industry spectrum and managed public reporting and Sarbanes Oxley compliance. Bringing over twenty five years capital markets experience, Mr. Taylor has held the NASD Series 7, 24 and 63 licenses, been a Registered Director with the SFA (UK) and is a Fellow of the Securities Institute in the United Kingdom. Formerly, Mr. Taylor was an executive with County Natwest Securities, a leading International Investment Bank, and a Director and Compliance officer of an NASD and SFA broker dealer where he was responsible for its successful transition into investment banking. He is also a Director and major shareholder of UK based Villa Care Ltd., a care home operating and property company and, since 2009, a founding group member of American Scientific Resources, a medical device company that led the way in the development of IR Thermometry. Mr. Taylor served as a Director of American Scientific Resources from 2011 to 2012. He is 53 years of age and is a resident of the United Kingdom.
2 --------------------------------------------------------------------------------Daniel J. Schreiber, Director Since 1997 Mr. Daniel Schreiber has served as the Chief Executive Officer and President of Avior Capital, LLC. At Avior, Mr. Schreiber sources and structures real estate and corporate finance transactions, and oversees the firm's investment banking team. Mr. Schreiber began his career at Shearson Lehman where is he was a Director Counsel member. Mr. Schreiber is 48 years of age and is a resident of California.
Item 9.01 Financial Statements and Exhibits 10.1 Asset Purchase Agreement with American Medical Distributors dated March 31, 2014.
10.2 Assignment Agreement between American Medical Distributors and HuBDIC 10.3 HuBDIC Co. Ltd Distribution Agreement dated November 27, 2013
this phone# is still being answered, good luck trying to understand what the recording says......
American Scientific Resources Inc.
83 South Putt Corners Road
PO Box 819
New Paltz New Jersey 12561 U.S.A.
Phone: 845-255-2200 Fax: 845-255-3299
did anyone else notice that the open was .003,
Last Price Today’s Change Bid (Size) Ask (Size) Day’s Range Volume Trade
0.0016 -0.0004 (-20.00%) 0.0017 x980,000 0.0019 x2,562,500 0.0016 - 0.003 7,106,642
OTC Pink - Current Information Real Time Quote Last Trade as of 11:05 AM ET 4/7/14 Extended Hours Quote and Chart: Show|Hide
Open 0.003
Previous Close 0.002
52 - Week Range 0.0005 - 0.0082
1/31/14 - 4/8/13
Avg Volume (10 days)19,191,458
P/E (Trailing 12 mo.)
1.03x
EPS (Trailing 12 mo.)
0.00195
Next Earnings Date--
Market Cap 1.1 M
Shares Outstanding 701.3 M
Beta
from my dd, and from other postings, $$CLNP$$ IS GOING TO BE A WINNER. MAYBE NOT TOMORROW OR NEXT WEEK, BUT IM HOLDING ON FOR THE NEXT 9-18 MONTHS FOR THIS WONDERFUL LONG PLAY. I WILL ACCUMULATE AND HOLD STRONG. I WILL GET GREAT PPS FOR NOW, SO THEN I WONT HAVE TO CHASE THE PPS AS IT INCREASES .... LMAO ALL THE WAY TO THE BANK.. GO $$CLNP$$
congrats to whom ever got that, we wont be seeing the trips for much longer imho. it just about that time $$CLNP$$ has that up-trend. go $$CLNP$$....
i have been on board for 5 years with $$MDIN$$, i have made some good profits here, now im long and strong. not flipping or short. this was dormant for over a year at .0001, i had a nice chunk then and waited it out till nick came aboard, then i made a ton of cash and i chased it up. now im comfortable and long. good luck to all here. go $$MDIN$$....
long and strong here. im thinking that for $$CLNP$$ to start their up-turn, it will be approx. 3-6 months. imo, ken is going in the right direction with the company. go $$CLNP$$....
as you see, some are very up-set at the new things thats happening with $$MDIN$$. they should have never sold at a loss. its their fault that they had no faith and dont want anyone else to enjoy their profits. im also here at a lower then pps is right now, :)---- goes to show you that in the pinkies, sometimes they will surprise you. im long and strong, go $$MDIN$$....
i would really like to see ken let us know what happened with his meetings last week. he let us know there were meetings and he should follow up with that. im not worried about the pps right now, imo it will bounce back and then some. im just waiting...... go $$CLNP$$....
being that nick doesn't put out pr's on a Friday, im hoping that tuesday he puts it out, i wanna add more here on monday, lol. iimo, he is going to mention the new v.p., and walgreens. im also hoping he has the audited financials ready or at-least the quarterly done. in any case, $$MDIN$$ is on its way up, and im here for the long ride. go $$MDIN$$....
nick has learned alot in the last 1.75 years. if he is waiting to pr the walgreens.com and the new v.p., then he has a reason. i knew from the get-go that this was/is a long play. go $$MDIN$$....
congats on whom-ever got those 15;s. i wish it was me. ohh well, it seems that nick now has a v.p., $$MDIN$$ is looking and progressing to be a competitor in the "real business world". this has been his plans from the very start, nick said he was going to grow this company to compete in the business world of health-care and there alike. well, from what i see now. he is very close to his goal. he also stated he was going to make north-star a company that other companies wanted to acquire. well, it seems he has achieved that goal also. all in imho. go $$MDIN$$.....
or maybe this will help a little more........
pluricells.com Stem Cell Therapy Treament
A Revolution in Stem Cell Therapy
All humans possess pluripotent stem cells which appear to equal embryonic stem cells in their ability to differentiate into a wide variety of tissue types.
PluriCells™ are excellent candidates for regenerative medicine, ideal for restoration of damaged tissues.
A New Discovery in Stem Cell ResearchMore Info
123
What are Pluricells
Pluripotent Cells
Purpose of Pluricells
Advantages
PluriCells Location
Differences
Summary/Overview
What are PluriCells™
1251878_77186710
PluriCells™ are autologous adult stem cells. These cells have the potential to revolutionize the treatment of human disease, reverse the effects of aging and promote general health. There are over twenty types of stem cells that have now been discovered in the body. Some are unipotent, multipotent, and some are pluripotent.
The primary objective of this information web site is to inform people that all humans possess their own highly plastic pluripotent stem cells which appear to equal embryonic stem cells in their ability to differentiate into a wide variety of tissue types, thus PluriCells™ can be used to improve healing.
PluriCells™ are excellent candidates for regenerative medicine as highly plastic stem cells that are ideal for restoration or replacement of damaged tissues.
Read More
maybe this will help you out pattiA........
Stem Cell Innovations' PluriCells(TM) to Form the Basis of a Liver Assist Device...
Thu Feb 5, 2009 6:00am EST
* Reuters is not responsible for the content in this press release.
0 COMMENTS
Stem Cell Innovations' PluriCells(TM) to Form the Basis of a Liver Assist
Device to Support Patients Waiting for Transplant.
HOUSTON, Feb. 5 /PRNewswire-FirstCall/ -- In a paper published in the most
recent issue of Current Gastroenterology Reports, Drs. Norman L. Sussman,
Brendan M. McGuire and James H. Kelly describe the need and requirements for a
successful liver assist device. "There are currently three times as many
patients on the waiting list for liver transplantation as there are organs
available and few ways to stabilize them if they enter an acute phase of their
disease," said Kelly, CEO of Stem Cell Innovations, Inc. (OTC Pink Sheets:
SCLL).
This second generation device, based on the PluriCells, "combines the safety
of primary hepatocytes (normal liver cells) with the standardization of a cell
line," continued Kelly. "We're building on what we learned from our earlier
device which utilizes the C3A cells that form the basis of Stem Cell
Innovations' ACTIVTox(R) drug discovery products. We are one of the few
companies that can approach this problem from both sides: from the stem cell
and from the adult liver cell. We are using our PluriCell(TM) system to
understand the requirements of the liver stem cell and our ACTIVTox system to
understand the requirements of the mature cell."
Liver disease is a serious problem in the United States and worldwide. There
are about 6,500 liver transplantations performed each year in the US, with
about 16,000 on the waiting list, about 1,800 of whom will die each year
without receiving an organ. A liver assist device would be expected to first
find use in such acute cases but could be used more widely as experience
grows.
Dr. Norman L. Sussman, MD is currently Director of Hepatology at the
University of Utah School of Medicine and is also a Director of Stem Cell
Innovations. Dr. Brendan M. McGuire, MD is an Associate Professor of Medicine
at the University of Alabama School of Medicine and is not affiliated with
SCLL.
About Stem Cell Innovations, Inc.
SCLL is a cell biology company based in Houston, TX. The Company's ACTIVTox
system is a human liver based model for high throughput toxicity testing.
Stem Cell Innovations proprietary, human pluripotent stem cells, known as
PluriCells, have the potential to aid in drug discovery, toxicology, and cell
therapy.
Additional information is available at www.stemcellinnovations.com and at
www.activtox.com.
ACTIVTox and PluriCells are Trademarks of Stem Cell Innovations, Inc.
Forward Looking Statement
This release contains forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. The Private Securities
Litigation Reform Act of 1995 provides a "safe harbor" for forward looking
statements. Forward-Looking statements are not statements of historical
facts, but rather reflect our current expectations concerning future events
and results. We use words such as "expects", "intends", "believes", "may",
"will" and "anticipates" to indicate forward-looking statements. Because
these forward-looking statements involve risks and uncertainties, there are
important factors that could cause actual results to differ materially from
those expressed or implied by these forward-looking statements, including, but
not limited to, those risks and uncertainties detailed in the Company's
periodic reports filed with the Securities and Exchange Commission. We
caution that these risk factors may not be exhaustive. We operate in a
continually changing business environment, and new risk factors emerge from
time to time. We cannot predict these new risk factors, nor can we assess the
effect, if any, of the new risk factors on our business or the extent to which
any factor or combination of factors may cause actual results to differ from
those expressed or implied by these forward-looking statements.
If any one or more of these expectations and assumptions proves incorrect,
actual results will likely differ materially from those contemplated by the
forward-looking statements. Even if all of the foregoing assumptions and
expectations prove correct, actual results may still differ materially from
those expressed in the forward-looking statements as a result of factors we
may not anticipate or that may be beyond our control. While we cannot assess
the future impact that any of these differences could have on our business,
financial condition, results of operations and cash flows or the market price
of shares of our common stock, the difference could be significant. We do not
undertake to update any forward-looking statements made by us, whether as a
result of new information, future events or otherwise. You are cautioned.
SOURCE Stem Cell Innovations, Inc.
Dr. James H. Kelly of Stem Cell Innovations, +1-281-679-7900,
Kelly@stemcellinnovations.com
nick has gotten 100% better in putting out pr's, he words them better and doesn't speculate with things might be happening. he will pr after an event has happened. he has learned his lessons the hard way for the past 2 years approx. i am very confident with ALL of the decisions nick has made thus far. i am long and strong, go $$MDIN$$.....
nick has never, and said he will never put out a press release on a Thursday or Friday. go $$MDIN$$....
this is for the ones that said ken lewis is full of it......
DEC 20
BioSwan Inc. A Hemp Inc. Company
Hemp, Inc. Announces BioSwan, Inc.
BioSwan Inc. A Hemp Inc. CompanyHemp, Inc. is proud to announce the naming of BioSwan, Inc., a new spin-off of Hemp, Inc., dedicated to improving the quality of life via its proprietary all natural formulations and modalities designed to increase the body’s production of pluripotent adult stem cells. Hemp, Inc. has agreed to spin the company off and to retain a two-year exclusive contract for marketing the herbal blends that have been shown to increase the body’s production of these most valuable pluripotent stem cells.
Bruce Perlowin, CEO of Hemp, Inc., stated, “This could be an enormous benefit to Hemp, Inc. shareholders. While our research uncovered the valuable herbal blends that increase the specific stem cells, it is outside of Hemp’s core business and detracts from the management team’s ability to focus. By spinning it off, the shareholders receive stock in BioSwan, Inc. This spinoff will have a dedicated and focused management team completely separate from Hemp, Inc. thereby allowing Hemp, Inc. improved focus. Everyone wins.”
The National Institute of Health resource for stem cell research defines Pluripotent as, “the state of a single cell that is capable of differentiating into all tissues of an organism.” Pluripotent adult stem cells are rare and generally small in number but can be found in a number of tissues.
Current adult stem cell research targets the capacity of the cells to divide or self-renew indefinitely. Bone marrow stem cell, whose quantity declines with age, has been found to be one of the rich sources of adult stem cells, and has been used in treating Spinal cord injury, Liver Cirrhosis, Chronic Limb Ischemia, and Endstage heart failure. Adult stem cell treatments have been successfully used for many years to treat leukemia and related bone/blood cancers through bone marrow transplants. Adult stem cells are also used in veterinary medicine to treat tendon and ligament injuries in horses.
The National Institute of Health website states: “Imagine if doctors were able to reverse age-related, chronic degeneration and bring the body back to its original health and vigor”. The website continues, “A study in mice found that function could be restored to injured muscle tissue by reactivating existing stem cells rather than transplanting new ones” and that, “The ability to reactivate dormant adult stem cells continues to be investigated.”
Hemp, Inc. President David Tobias continued, “Aging is an issue that affects everyone, and it is gratifying to be able to participate and assist in a venture to improve health and the quality of life.”
ABOUT HEMP, INC.
Hemp, Inc. HEMP -11.14% focuses on the vast market created by the quickly emerging, and growing, multibillion dollar industrial hemp industry. Hemp, Inc. HEMP -11.14% is not involved in the cultivation or marketing of medical marijuana. It is the company’s belief that legalization of hemp in all 50 states and at the federal level will come to pass. With that in mind, the company is building infrastructure with the potential to gain substantial market share before and after industrial hemp prohibition ends. (Pending any federal licensing or other requirements, that may be enacted after hemp prohibition ends).
CONTACT:
Phone: 1-877-221-8351Email: info@hemp.com http://www.hemp.com (Hemp, Inc.) http://www.hempincnews.com (Hemp, Inc. News) http://www.herbagenix.com (Hemp-Based Supplements Division) http://www.basichemp.com (Hemp Protein with Enhanced Nutritionals) http://www.mjlover.com (MJ LOVER for Him; MJ LOVER for Her) http://www.re-load.biz (Hemp-Based Nutraceuticals) http://www.ecoharmonycards.com (Loyalty Card Sustainable Fundraiser for Non-Profits) http://www.supportpatchadams.com (Hemp Gemstone Candles and Fundraiser for Patch Adams) http://www.hempinc.tv (Media and Entertainment Division)
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Hemp, Inc. to be materially different from the statements made herein.
SOURCE Hemp, Inc.
Other stories you might be interested in:
Hemp History Week
Hemp and Marijuana Industry Flourish
Hemp, Inc. Update Regarding its Spin-offs
Kush Inc. – Hemp Based Skin Care Products
tweet,tweet,tweet.........
my take on that responce from dixie elixer is, when they said that [b]"We had a half hour phone call and that was it. We subsequently discontinued those discussions when they chose to post that misleading press release." thats when they were getting all those ph. calls that nick talked about and decided to with-draw from doing biz with northstar. so nick did not lie about anything and it was a bunch of fools that deciced to ruin negotiations with dixie elixier. go $$MDIN$$
nice open, lets keep it going.... go $$MDIN$$
i would really like to see the short report for the day today, if there is any shorting. if no shorting you will see actually volume #'s. this will work in $$mdin$$'S favor. go $$MDIN$$....
ok, another tweet from ken this afternoon,........
this in to twitter 45mins ago...........
[quote]Nick Chieco CEO ?@MedGenInc 44m
I want to assure everyone that any increases in float are for a reason and there are no plans for any reverse splits in our future.[/quote]
hi firebag1, you have been around for a long time, me to. i remember when snorenz and re-juv was being sold, take a look at who has the rights to snorenz now, mdin. they were dormant for over a year till the new ceo took it over and now its doing pretty good. good luck to all....
hi, did anyone here know about the connection to mdin? this is from a pr this morning......
Northstar taps leading cannabis manufacturers to produce prototypes of new medical marijuana products
Mar 10, 2014 09:00:00 (ET)
HOLBROOK, N.Y., March 10, 2014 /PRNewswire/ -- Northstar Global Business Services, Inc., (OTC-PINK:MDIN) today announced that the company has begun to develop a new product line with the help of several top medical marijuana industry leaders like Dixie Elixirs, a marijuana manufacturer recently featured on 60 minutes, and Kush Creams, another marijuana product manufacturer who has received many awards for their excellency in producing medical marijuana products going back as far as 2008. Northstar management feels that by tapping into the leading sources in the business, the new product line will gain the experience and existing distribution network needed to quickly make the company a leader as well.
The new products being developed feature Northstar's patented oral spray delivery system, for such uses as a THC oral spray, and a THC and snoring solution. Since one of the most popular reasons patients are prescribed medical marijuana is for sleeping disorders, the products cover several bases at once giving patients one solution to several problems. Northstar also feels that a spray can be the most effective and safest delivery system for medical marijuana, but previous attempts by other companies to make an oral THC spray always fell short. However, by applying Northstar's many years of experience with oral spray technology, the company feels it can use the oral spray effectively, and become the most popular delivery method for medical marijuana patients.
"We think our spray technology is the answer for THC delivery, and it seemed only natural that we partner with only the best in the business. We bring tremendous strengths to the table, and these strengths coupled with powerhouse marijuana product producers like Dixie Elixirs, Kush Creams and several others, make for an unstoppable combination in my opinion," said company CEO, Nick Chieco.
Although, no release dates are currently set for any specific products, the company has very high expectations and feels that having a hand in one of the fastest growing industries in the world, will give Northstar an edge in both the medical marijuana and traditional alternative healthcare industries.
About Northstar
Northstar Global Business Services is dedicated to producing the best alternative healthcare products to the world. The company's product line includes Snorenz(R), Good Night's Sleep(R), Stem-Intense, and most recently in development is a line of medical marijuana oral sprays. Most of the company's products use a unique or patented spray delivery system, and all have received rave consumer reviews all over the world, selling millions of units from 1996 to the present. More information can be found at www.medgeninc.com.
DISCLAIMER
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.
SOURCE Northstar Global Business Services, Inc.
/CONTACT: Investor Relations, investors@medgeninc.com, 877-571-4387
/Web site: http://www.medgeninc.com
(END) Dow Jones Newswires
March 10, 2014 09:00 ET (13:00 GMT)
my wife said i do not need to try the male enhancement, but the nutra-load, and energy drink i have tried and liked. i still have 3 full and 1 almost gone of the bottles of nutra-load. that is after i used 2 bottles of them already. love the products i used. they will catch on and will become a house-hold product. go $$CLNP$$....
where do you get that nick chieco is from waste management? as far as i know he and ray are from suffolk county police force. go $$MDIN$$....
do you know what happens with the shares that were already borrowed?
webber2, i agree with you. nick never puts any kind of news out on a Friday, saying that imo, he is setting up a news/pr frenzy and its going be explosive here. im not a chart guy, but from what some are saying the charts are all coming together and between the toxic debt being taken care of, and banking of shares for acquisition/merger, boy am i excited. i said this along time ago, "$$mdin$$ is going to be my mini Google". go $$MDIN$$.....
im pretty sure that nick said in a tweet or shareholders letter, or maybe in a pr that he was going to get even with the manipulators and the shorter's. well it has come, and he will be getting even with them for doing what they have done to $$MDIN$$ for the last year. i really thought it would take another 6-9 months for everything to come together, i guess not. good luck to all, go $$MDIN$$.....
they are just starting the tests, the results should be known in a few months as to the results of re-ordering or not. if the results are good we will hear about it, if the results arent what they expect, dont plan on hearing about it. im hopeing the results are great. but again, dont plan on hearing anything about it for a few months. go $$CLNP$$....
read very carefully, it means alot.